Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Judy
Contact Judy, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck RackActions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Articles
A Pharmacokinetic and Biomarker Study of Delayed-Release Dimethyl Fumarate in Subjects with Secondary Progressive Multiple Sclerosis: Evaluation of Cerebrospinal Fluid Penetration and the Effects on Exploratory Biomarkers
Highlights • Tmax of CSF MMF peak is 2 hours after plasma showing MMF crossing the blood brain barrier with potential direct penetration into the brain. • NfL CSF levels and GFAP show correlation with disease activity in SPMS • CSF NfL increase is significantly elevated and precedes clinical symptoms by many weeks • CSF NfL returns to baseline consistent with clinical improvement Abstract Background Biomarkers are a useful and reliable measure of disease activity in many fields of medicine.
Neurofilament light chain as an indicator of exacerbation prior to clinical symptoms in multiple sclerosis
To view the full text, please login as a subscribed user or purchase a subscription. Click here to view the full text on ScienceDirect. Figure 1 NfL levels of CSF at baseline, 6-weeks, 28-weeks in the 16 patients with case report showing spike of NfL at 6-weeks.
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Judy
Contact Judy, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack